IMMUNYX PHARMA USA INC.
A new paradigm for immune modulation
New York, United States · Founded 2025 · $1.0M raised
- Headquarters
- New York, New York
- Employees
- 1–10
- Founded
- 2025
- Business Model
- B2B
- Website
- immunyx.com
- Total Funding
- $1.0M
- Last Round
- $1.0M GrantSep 2025
- Rounds
- 1
About
Immunyx is a drug development company pioneering neutrophil modulation therapies for chronic diseases including COPD, cancer, colitis, and arthritis. Using novel pharmacological approaches, the company targets deregulated neutrophil activity — a mechanism largely unaddressed by existing FDA-approved therapies. Its leadership team comprises world experts in neutrophil biology, nanoparticle delivery, and clinical development.
Summary
IMMUNYX PHARMA USA INC. is a Biotech company based in New York, United States, founded in 2025. It has raised $1.0M in total across 1 round, most recently a $1.0M Grant round in Sep 2025.
Tech & App Stack
5 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sep 2025
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/immunyx-pharma-usa-inc"><img src="https://indexed.vc/api/badge/company/immunyx-pharma-usa-inc" alt="IMMUNYX PHARMA USA INC. on Indexed.vc" width="260" height="76" /></a>